Delivery Order SPE2DX22D0010-SPE2D824FMC98
- Not listed
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, by the Medical Supply Chain, an alternate name for the Defense Logistics Agency (DLA) Troop Support Medical. The $26,282.30 firm-fixed-price contract covers the provision of a variety of pharmaceutical products and medical supplies to the DLA, without any set-aside designation. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a Delivery Order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $67,684.95, is for the provision of pharmaceutical products and medical supplies to the DLA. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...
- This is a delivery order award to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,606.41 firm fixed-price contract is for the supply of various pharmaceutical products and medical supplies to support military treatment facilities and federal healthcare programs. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This is a delivery order award by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a firm fixed price of $1,033.50 and a completion date of December 24, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $2,948.39 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD). The $1,991.25 firm fixed-price contract is for the provision of pharmaceutical products and medical supplies, including a wide range of prescription medications, over-the-counter drugs, and medical devices and supplies. The award is associated with a larger Indefinite Delivery Contract (IDC) held...
- This is a delivery order award to Amerisourcebergen Drug Corp, Corporate Office Division, under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,701.15, is for the provision of pharmaceutical products and medical supplies to the DLA. Amerisourcebergen, a major pharmaceutical distribution company, is the prime contractor and has no set-aside designation for this award. The IDC with the DLA, valued up to...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The contract, valued at $928,594.82, is for the provision of a variety of pharmaceutical products and medical supplies to support the Department of Defense's healthcare programs and facilities worldwide. Amerisourcebergen, a major pharmaceutical distributor, holds a $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care...
- This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $190,087.75 firm-fixed-price contract provides a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. Amerisourcebergen holds a $999,999,999 Indefinite...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D824FMC98Delivery Order
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,064.72 firm fixed price award is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This IDC enables the DLA to efficiently procure essential medical commodities, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits, for military treatment programs and facilities globally. Amerisourcebergen also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 5/1/24 |